by Surgical Synergy
Innovation in Keyhole Surgery
£498THOUSANDInvested to date
£1.25MILLION
Fundraise 2016/17
15.0%EQUITYShareholding
EIS APPROVED
Tax efficiency
3x PATENTS
2x FUTURE
Products Planned
$45 BILLION
Market by 2020
Founder & Inventor One of the world’s pioneering Endoscopic spine surgeons.
Martin Knight Chairman &
Chief Medical Officer
Our award winning design partner
2000+SURGEONS
PREFORM HIS TECHNIQUES
25+PUBLISHED
JOURNAL CREDITS
32+PUBLISHED
NON JOURNAL CREDITS
3xIP
PATENTS
Martin Knight Chairman &
Chief Medical Officer
Ieuan Griffiths CEO
Potential Distributors
Roger JohnCTO
TEAM
Challenging Times for Healthcare
“New medical devices are attempting to provide surgeons with high-efficiency multifunctional devices that cut costs over time.”
#Healthcare Funding Crisis
“This new emphasis on managing and decreasing postoperative patient recovery times could allow laparoscopy to tap into a significantly larger patient pool”.
www.meddeviceonline.com
Endoscopy Looking inside the body to examine the interior of a hollow organ or cavity
Laproscopy Keyhole surgery performed through small incisions
Instruments repeatedly changed between access portals
Endoscope (Camera) needs to change position
Single view-point
Blunt or failing instruments
Endoscope is rigid.
Assistant provides the wrong instrument
Challenging ops need more incisions
Abdominal & Pelvic Surgery
A Simple Solution
CAMERA & LIGHT
6x Tools
Improved Vision - Disposable Tips - Novel Cassette - Always Sharpe
3x Patents2x to follow
Quicker & Less Invasive Operations
Medusascope™
Reduces incision Better patient outcomesFrees up hospital beds
Reduces operation timesFewer infections
Reduce costs
Medusascope™
Close up view 2nd angle of vision
Reduces operating risk30% quicker instrument change
Less surgeon fatigueTools always sharp
Medusascope™
Fewer incisionsImproved patient satisfaction
Better health outcomesFewer port-site complications
Less post-operative pain Faster recovery
PATIENTSSURGEONSHOSPITAL
FUNDED FUNDING
FUNDING
TODAY
2015Q3
2016Q4
12+ Months
18 Months
£498kFUNDING
£1.25MILLION
£4MILLION
PHASE ONEProof of Concept / Working Prototype
Basic working prototype confirming technical feasibility. Refinement of prototype for initial
testing completed Q4 2016.
PHASE TWOOptimise DesignMarket TestingClinical Testing
Pre-Production SpecificationCamera Software DevelopmentIntegration to theatre systemsApplication for accreditation
PHASE THREEDevelopment of Flexible Version
Small Bore Version from 6.3mm to 2.8mm
Accreditation FDA USA & CE for Europe
£86kFOUNDER
£300kINVESTORS
£112kGRANT
PHASE THREE PHASE TWO PHASE ONE
£212THOUSAND
sales
2017 2018 2019 2020 2021 2022
£1.7mEBITDA
£9mEBITDA
£20mEBITDA
£1.8MILLION
sales
£9.1MILLION
sales
£28MILLION
sales
£62MILLION
sales
£300MILLION
EXIT*
* Recent exits show 15x EBITDA as an average. Appendix highlights recent acquisitions and exits.
£1.25MILLION
£4MILLION
FUNDING ROUND FUNDING ROUND
Use of Funds & Future Goals
Development of Flexible Version Small Bore Version
from 6.3mm to 2.8mmAccreditation FDA USA &
CE for Europe
Optimise DesignMarket TestingClinical Testing
Pre-Production SpecificationCamera Software DevelopmentIntegration to theatre systemsApplication for accreditation
ASIA-PacificFastest Growing Market
8.6%CAGR to 2020
32%USA
33%Rest of the
World
25%EUROPE
10%JAPAN
13%of all Obese People Live in US
Fuelling the rise in Bariatrics Keyhole Surgery
Global Laparoscopy Devices Market (Abdominal cavity surgery only)
2025
33.8%Global Laproscopic
Instruments Market 2016
39%US Laproscopic
Device Market 2015
$7.9BILLION
2014
$16.3BILLIONWhy is it Growing?
Rise in 60+ Age Group
Increase in Obesity
Advances in Technology
Lower cost of Key Hole Surgery
Increased Awareness
15MILLION
Key Hole Surgeries Performed Globally
7.5% CAGR2016 to 2025
TOP 5 COMPETITORS
Ethicon, a medical device company of Johnson & Johnson commands 39% of the US market.
by Surgical Synergy
THANK YOU